DE:FP1 / Salarius Pharmaceuticals, Inc. - Participation institutionnelle - Acheteurs

Salarius Pharmaceuticals, Inc.
DE ˙ DB
12,91 € ↑0,01 (0,08%)
2019-07-25
PRIX DE L'ACTION
Participation institutionnelle et des fonds - Acheteurs

Les principaux détenteurs qui ont ouvert de nouvelles positions dans Salarius Pharmaceuticals, Inc. comprennent Hrt Financial Lp, Cubist Systematic Strategies, LLC, Goldman Sachs Group Inc, Barclays Plc, et Mount Yale Investment Advisors, LLC .

Cette page montre les changements dans la structure de participation en listant les institutions, les fonds et les principaux actionnaires qui ont augmenté leurs avoirs ou ouvert de nouvelles positions au cours de la dernière période de déclaration. Les lignes vertes indiquent les nouvelles positions. Cliquez sur l'icône du lien pour voir l'historique complet des transactions.

Passez au niveau supérieurpour débloquer des données premium.

Date de dépôt Source Investisseur Type Prix moyen
(Est)
Actions Δ Actions
(%)
Valeur déclarée
(1000 $)
Δ Valeur
(%)
Allocation de portefeuille
(%)
2025-08-14 13F/A Barclays Plc 8 024 0
2025-08-14 13F Bank Of America Corp /de/ 18 50,00 0
2025-07-24 NP FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 9 353 64,78 7 16,67
2025-08-11 13F Citigroup Inc 5 889 5
2025-08-14 13F Goldman Sachs Group Inc 16 667 15
2025-08-08 13F Geode Capital Management, Llc 15 560 35,27 14 62,50
2025-08-12 13F Proequities, Inc. 0 0
2025-08-13 13F Mount Yale Investment Advisors, LLC 61 0
2025-08-14 13F Cubist Systematic Strategies, LLC 16 727 15
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-12 13F Proequities, Inc. Call 0 0
2025-07-24 NP FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 7 028 323,63 5 400,00
2025-08-15 13F Tower Research Capital LLC (TRC) 3 663 10,03 3 50,00
2025-08-14 13F Hrt Financial Lp 31 676 0
Other Listings
US:SLRX 4,64 $US
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista